Vertex sues US over fertility support program for Casgevy gene editing therapy
(Reuters) – Vertex Pharmaceuticals sued the U.S. Department of Health and Human Services on Monday, seeking a court declaration that a fertility support program for patients who are prescribed its gene editing therapy Casgevy does not violate federal anti- …